XML 18 R4.htm IDEA: XBRL DOCUMENT v3.23.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) (unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
REVENUES:        
Total revenues $ 617,397 $ 276,219 $ 904,992 $ 554,764
EXPENSES:        
Cost of goods manufactured and sold (exclusive of amortization of acquired intangible assets shown below) 63,260 58,360 121,435 113,519
Research and development 100,788 92,873 194,425 188,826
Selling, general and administrative 205,258 150,377 379,735 295,429
Amortization of acquired intangible assets 8,898 9,066 17,698 18,032
Total expenses 378,204 310,676 713,293 615,806
OPERATING INCOME (LOSS) 239,193 (34,457) 191,699 (61,042)
OTHER INCOME (EXPENSE), NET:        
Interest income 6,769 896 11,735 1,469
Interest expense (5,684) (2,369) (10,972) (4,719)
Change in the fair value of contingent consideration   870   (18,197)
Other (expense) income, net (525) 1,810 (564) 4,241
Total other income (expense), net 560 1,207 199 (17,206)
INCOME (LOSS) BEFORE INCOME TAXES 239,753 (33,250) 191,898 (78,248)
INCOME TAX PROVISION (BENEFIT) 2,688 (3,114) (3,322) (12,209)
NET INCOME (LOSS) $ 237,065 $ (30,136) $ 195,220 $ (66,039)
EARNINGS (LOSS) PER ORDINARY SHARE:        
Basic $ 1.43 $ (0.18) $ 1.18 $ (0.4)
Diluted $ 1.38 $ (0.18) $ 1.14 $ (0.4)
WEIGHTED AVERAGE NUMBER OF ORDINARY SHARES OUTSTANDING:        
Basic 166,279 163,839 165,686 163,165
Diluted 171,553 163,839 170,747 163,165
COMPREHENSIVE INCOME (LOSS):        
Net income (loss) $ 237,065 $ (30,136) $ 195,220 $ (66,039)
Holding gain (loss), net of a tax provision (benefit) of $99, $326, $587 and $(1,055), respectively 692 (2,254) 3,452 (6,765)
COMPREHENSIVE INCOME (LOSS) 237,757 (32,390) 198,672 (72,804)
Product sales, net        
REVENUES:        
Total revenues 231,477 190,787 446,204 362,055
Manufacturing and royalty revenues        
REVENUES:        
Total revenues 385,913 85,326 458,775 190,496
License revenue        
REVENUES:        
Total revenues       2,000
Research and development revenue        
REVENUES:        
Total revenues $ 7 $ 106 $ 13 $ 213